Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 2021 to 2030 of 2607 total matches.
In Brief: A New Prostate Cancer Indication for Olaparib (Lynparza) (online only)
The Medical Letter on Drugs and Therapeutics • Jun 26, 2023 (Issue 1679)
)-negative, high-risk
early breast cancer who received prior neoadjuvant
or adjuvant chemotherapy.1 It had ...
The oral poly(ADP-ribose) polymerase (PARP)
inhibitor olaparib (Lynparza – AstraZeneca) has now
been approved by the FDA for use in combination
with abiraterone (Zytiga, and others) and either
prednisone or prednisolone for treatment of adults
with deleterious or suspected deleterious BRCA-mutated
(BRCAm) metastatic castration-resistant
prostate cancer (mCRPC). Olaparib was previously
approved by the FDA for treatment of adults with
deleterious or suspected deleterious germline or
somatic homologous recombinant repair (HRR) genemutated
mCRPC who progressed on prior treatment
with...
Med Lett Drugs Ther. 2023 Jun 26;65(1679):e106-7 doi:10.58347/tml.2023.1679g | Show Introduction Hide Introduction
Shockwave Therapy for Erectile Dysfunction
The Medical Letter on Drugs and Therapeutics • Nov 27, 2023 (Issue 1690)
recommend using shockwave therapy only in the setting of a clinical trial.1
THE DEVICE — Low-intensity ...
Low-intensity extracorporeal shockwave therapy
similar to that used to fragment kidney stones or
gallstones is a new option for treatment of erectile
dysfunction that is now being advertised extensively
in the US. It has not been approved by the FDA for
treatment of erectile dysfunction.
Med Lett Drugs Ther. 2023 Nov 27;65(1690):190-1 doi:10.58347/tml.2023.1690d | Show Introduction Hide Introduction
Beqvez — Another Gene Therapy for Hemophilia B
The Medical Letter on Drugs and Therapeutics • Jun 10, 2024 (Issue 1704)
to
be approved in the US for treatment of hemophilia B;
Hemgenix was the first.1
AAV = adeno-associated virus ...
Fidanacogene elaparvovec-dzkt (Beqvez – Pfizer),
an adeno-associated virus (AAV) vector-based gene
therapy, has been approved by the FDA for treatment
of adults with moderate to severe hemophilia B who
do not have neutralizing antibodies to AAV serotype
Rh74var and currently receive factor IX prophylaxis
therapy or have had life-threatening hemorrhage or
repeated, serious, spontaneous bleeding episodes.
Beqvez is the second single-dose gene therapy to
be approved in the US for treatment of hemophilia B;
Hemgenix was the first.
Med Lett Drugs Ther. 2024 Jun 10;66(1704):95-6 doi:10.58347/tml.2024.1704d | Show Introduction Hide Introduction
Eroxon — An OTC Gel for Erectile Dysfunction
The Medical Letter on Drugs and Therapeutics • Nov 11, 2024 (Issue 1715)
with nitrates.1-3
Alternatives for management of ED include vacuum
erection devices, intraurethral ...
The FDA has authorized over-the-counter (OTC)
sale of a nonmedicated alcohol-based gel (Eroxon –
Futura) for treatment of erectile dysfunction (ED) in
males ≥22 years old. Eroxon is the only FDA-approved
OTC and topical treatment for erectile dysfunction. It
is also available in the UK and the EU.
Med Lett Drugs Ther. 2024 Nov 11;66(1715):181-2 doi:10.58347/tml.2024.1715c | Show Introduction Hide Introduction
Cord Blood Banks
The Medical Letter on Drugs and Therapeutics • Oct 01, 2001 (Issue 1114)
)
October 1, 2001
REPRODUCED FOR
ONLINE USERS
CORD BLOOD BANKS
Pregnant women now often receive ...
Pregnant women now often receive promotional material from private cord blood banks urging them to save and store their babies' cord blood.
Sildenafil (Revatio) for Pulmonary Arterial Hypertension
The Medical Letter on Drugs and Therapeutics • Aug 15, 2005 (Issue 1215)
was needed.
1
Now the results of
such a study are about to be published, and the drug has
been approved ...
The Medical Letter reported last year that sildenafil (Viagra - Pfizer) appeared to be effective for idiopathic pulmonary arterial hypertension (PAH), but confirmation from a controlled trial was needed. Now the results of such a study are about to be published, and the drug has been approved by the FDA for this indication under the trade name Revatio.
Adacel and Boostrix: Tdap Vaccines for Adolescents and Adults
The Medical Letter on Drugs and Therapeutics • Jan 16, 2006 (Issue 1226)
of DTaP (acellular pertussis) vaccines.
1
Immunity against B. pertussis, whether
induced by childhood ...
The FDA has licensed Adacel (Aventis Pasteur) and Boostrix (GlaxoSmithKline), two new combination vaccines that include tetanus toxoid, diphtheria toxoid and acellular pertussis antigens (Tdap), for use as a booster in adolescents and adults. In the past, older children and adults were not re-immunized against pertussis because of concerns about reactions to the whole-cell vaccine previously used in younger children. The CDC Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) have recommended that either of the new Tdap vaccines replace routine...
Pregabalin (Lyrica) for Fibromyalgia
The Medical Letter on Drugs and Therapeutics • Sep 24, 2007 (Issue 1270)
at
bedtime and increase after 1-2 weeks to 75 mg at bedtime before going on to the manufacturer’s recommended ...
Pregabalin (Lyrica - Pfizer) is the first drug approved by the FDA for management of fibromyalgia. When it was first marketed, pregabalin, which is structurally similar to gabapentin (Neurontin, and others), was approved for treatment of neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy and for adjunctive treatment of partial onset seizures in adults with epilepsy. It has also been prescribed off-label for other types of neuropathic pain such as sciatica.
H1N1 Vaccine for Prevention of Pandemic Influenza
The Medical Letter on Drugs and Therapeutics • Oct 05, 2009 (Issue 1322)
hospitalizations have been in persons ...
The FDA has licensed 4 new monovalent vaccines for prevention of respiratory illness caused by a new influenza A H1N1 virus that appears to be derived from a swine strain. The 5th vaccine should be licensed soon. All of these vaccines are expected to become available in October. An intranasal formulation is expected in the first week of October.
Mercury in Fish
The Medical Letter on Drugs and Therapeutics • Dec 14, 2009 (Issue 1327)
Americans, seafood is
the major source of exposure to mercury.
1
The mercury in seafood is in the form ...
Recent news articles about mercury in fish may lead some patients to seek more information from their healthcare providers. For most Americans, seafood is the major source of exposure to mercury. The mercury in seafood is in the form of methylmercury, a potential neurotoxin formed by the organification of elemental mercury by marine microorganisms like plankton, which are then consumed by aquatic animals and concentrated up the food chain.